SHON is a novel biomarker predicting breast cancer response to endocrine therapy

被引：0

作者：

Liu, Dong-Xu ^{[1
]}

Abdel-Fatah, Tarek M. A. ^{[2
,3
]}

Jung, Yewon ^{[1
]}

Nolan, Christopher C. ^{[2
,3
]}

Huang, Baiqu ^{[4
]}

Li, Jun ^{[4
]}

Perry, Jo K. ^{[1
]}

Chan, Stephen Y. T. ^{[2
,3
]}

Green, Andrew R. ^{[2
,3
,5
]}

Ellis, Ian O. ^{[2
,3
,5
]}

机构：

[1] Univ Auckland, Liggins Inst, Auckland 1, New Zealand

[2] Univ Nottingham, Nottingham NG7 2RD, England

[3] Nottingham Univ Hosp NHS Trust, Nottingham, England

[4] NE Normal Univ, Changchun, Peoples R China

[5] City Hosp Nottingham, Nottingham, England

来源：

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE | 2013年 / 32卷

关键词：

D O I：

暂无

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

153

引用

页码：S18 / S18

页数：1

共 50 条

[41] The Emerging Role of ESR1 Mutations in Luminal Breast Cancer as a Prognostic and Predictive Biomarker of Response to Endocrine Therapy [J].

De Santo, Irene ;

McCartney, Amelia ;

Migliaccio, Ilenia ;

Di Leo, Angelo ;

Malorni, Luca .

CANCERS, 2019, 11 (12)

[42] Novel lipometabolism biomarker for chemotherapy and immunotherapy response in breast cancer [J].

Zhang, Lei ;

She, Risheng ;

Zhu, Jianlin ;

Lu, Jin ;

Gao, Yuan ;

Song, Wenhua ;

Cai, Songwang ;

Wang, Lu .

BMC CANCER, 2022, 22 (01)

[43] Predicting resistance to endocrine therapy in breast cancer: It's time for epigenetic biomarkers [J].

Fontes-Sousa, Mario ;

Amorim, Maria ;

Salta, Sofia ;

De Sousa, Susana Palma ;

Henrique, Rui ;

Jeronimo, Carmen .

ONCOLOGY REPORTS, 2019, 41 (03) :1431-1438

[44] Predicting nonadherence to adjuvant endocrine therapy in women with early stage breast cancer [J].

Corter, Arden L. ;

Broom, Reuben ;

Porter, David ;

Harvey, Vernon ;

Findlay, Michael .

PSYCHO-ONCOLOGY, 2018, 27 (09) :2096-2103

[45] Factors predicting response to chemo-endocrine treatment in advanced breast cancer [J].

Gieseking, F ;

Muller, V ;

Maass, H ;

Lindner, C ;

Janicke, F .

EUROPEAN JOURNAL OF CANCER, 1997, 33 :689-689

[46] POSSIBILITY OF PREDICTING RESPONSE OF PATIENTS WITH EARLY BREAST CANCER TO SUBSEQUENT ENDOCRINE ABLATION [J].

BULBROOK, RD ;

HAYWARD, JL .

CANCER RESEARCH, 1965, 25 (7P1) :1135-&

[47] Tumour immune subtyping as a predictive biomarker for adjuvant endocrine therapy in early breast cancer [J].

Blok, E. J. ;

Engels, C. C. ;

Jongste, E. ;

Dekker-Ensink, G. ;

Kroep, J. R. ;

Kuppen, P. J. K. ;

van de Velde, C. J. H. .

CANCER RESEARCH, 2016, 76

[48] BCAR4 Expression as a Predictive Biomarker for Endocrine Therapy Resistance in Breast Cancer [J].

Liao, Muheng ;

Webster, Jace ;

Coonrod, Emily M. ;

Weilbaecher, Katherine N. ;

Maher, Christopher A. ;

White, Nicole M. .

CLINICAL BREAST CANCER, 2024, 24 (04) :368-375.e2

[49] Mammographic density, endocrine therapy and breast cancer risk: a prognostic and predictive biomarker review [J].

Atakpa, Emma C. ;

Thorat, Mangesh A. ;

Cuzick, Jack ;

Brentnall, Adam R. .

COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (10)

[50] TFF3 is a valuable predictive biomarker of endocrine response in metastatic breast cancer [J].

May, Felicity E. B. ;

Westley, Bruce R. .

← 1 2 3 4 5 →